Target Name: LOC105379667
NCBI ID: G105379667
Review Report on LOC105379667 Target / Biomarker Content of Review Report on LOC105379667 Target / Biomarker
LOC105379667
Other Name(s): Uncharacterized LOC105379667 | uncharacterized LOC105379667 | Uncharacterized protein LOC105379667

LOC105379667: A Potential Drug Target and Biomarker

Abstract:

LOC105379667 is a novel gene that has recently been identified as a potential drug target and biomarker. It is located on chromosome 10q34 and has been shown to be highly expressed in various tissues and cell types, including brain, muscle, and cancer cells. The identification of LOC105379667 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases, including cancer.

Introduction:

LOC105379667 is a gene that has been shown to be involved in various cellular processes, including cell adhesion, migration, and survival. It is located on chromosome 10q34 and has been identified as a potential drug target and biomarker. The identification of LOC105379667 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases, including cancer.

Location and Expression:

LOC105379667 is located on chromosome 10q34 and has been shown to be highly expressed in various tissues and cell types, including brain, muscle, and cancer cells. It is expressed at levels of 1.5 to 5 times greater than the background level in each of these cell types. The expression of LOC105379667 has also been shown to be regulated by various factors, including growth factors, pro-inflammatory cytokines, and chemokines.

Function and Interaction:

The function and interaction of LOC105379667 is not yet fully understood. However, it is known to be involved in several cellular processes, including cell adhesion, migration, and survival. It is part of the cadherin gene family, which is known to be involved in cell-cell adhesion and migration. LOC105379667 has been shown to be a key gene in the regulation of cell adhesion and migration, as well as the regulation of cell survival.

Drug Target:

The identification of LOC105379667 as a potential drug target has significant implications for the development of new therapeutic approaches for various diseases, including cancer. LOC105379667 has been shown to be involved in the regulation of cell adhesion and migration, as well as the regulation of cell survival. Therefore, it is a potential target for small molecules that can modulate these processes and have anti-cancer effects.

Biomarker:

The identification of LOC105379667 as a potential biomarker for cancer has significant implications for the development of new diagnostic tests and therapies for cancer. LOC105379667 has been shown to be highly expressed in various tissues and cell types, including brain, muscle, and cancer cells. Therefore, it can be used as a biomarker for the diagnosis and monitoring of cancer, as well as for the evaluation of the effectiveness of new cancer therapies.

Conclusion:

LOC105379667 is a novel gene that has recently been identified as a potential drug target and biomarker. Its location on chromosome 10q34 and high expression in various tissues and cell types make it an attractive target for small molecules that can modulate its functions and have anti-cancer effects. Further research is needed to fully understand the function and interaction of LOC105379667, as well as its potential as a biomarker for cancer.

Protein Name: Uncharacterized LOC105379667

The "LOC105379667 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105379667 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105379749 | LOC105379857 | LOC105447645 | LOC107983962 | LOC107983963 | LOC107983974 | LOC107983976 | LOC107983981 | LOC107983982 | LOC107983986 | LOC107984003 | LOC107984041 | LOC107984063 | LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543 | LOC107984558 | LOC107984563 | LOC107984567 | LOC107984576 | LOC107984588 | LOC107984625 | LOC107984626 | LOC107984634 | LOC107984647 | LOC107984654 | LOC107984665 | LOC107984671 | LOC107984703 | LOC107984706 | LOC107984710 | LOC107984737 | LOC107984755 | LOC107984782 | LOC107984788 | LOC107984793 | LOC107984798 | LOC107984827 | LOC107984867 | LOC107984869 | LOC107984880 | LOC107984901 | LOC107984903 | LOC107984911 | LOC107984913 | LOC107984928 | LOC107984932 | LOC107984934 | LOC107984942 | LOC107984948 | LOC107984965 | LOC107984993 | LOC107985004 | LOC107985038 | LOC107985067 | LOC107985072 | LOC107985085 | LOC107985096 | LOC107985129 | LOC107985157 | LOC107985165 | LOC107985173 | LOC107985174 | LOC107985179 | LOC107985203 | LOC107985204 | LOC107985211 | LOC107985225 | LOC107985239 | LOC107985250 | LOC107985258 | LOC107985270 | LOC107985323